Mark Kawakami
CIK: 0002030709
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RKDA
Arcadia Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Kawakami Mark
Kawakami Mark (SEC CIK 0002030709) files insider reports with the SEC as Chief Financial Officer of Arcadia Biosciences, Inc. (RKDA).
Signal8 holds 2 ownership filings by Kawakami Mark, all Form 4s, filed between Feb 5, 2025 and May 12, 2025. Those filings report 2 transactions, from Feb 3, 2025 to May 9, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kawakami Mark's filings is in DALLAS, TX.
Recent filings by Kawakami Mark
Other insiders filing for Arcadia Biosciences, Inc. (RKDA)
- Yoder Amy, Director
- Comcowich Kevin, Director
- WALLER GREGORY D, Director
- Murray Lilian Shackelford, Director
- Schaefer Thomas J., Chief Executive Officer